Want to join the conversation?
$GILD's 3Q15 total HCV revenue was $4.8Bil, which decreased 2% QoverQ and increased 70% YoverY. In the U.S. HCV products revenue totaled $3.3Bil with Harvoni representing more than $2.5Bil. $GILD's hepatitis C drugs Sovaldi and Harvoni are now approved in 57 and 44 countries respectively.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.